Drug · DIN 02416638
IMVAMUNE
MODIFIED VACCINIA VIRUS, LIVE, ATTENUATED, NON REPLICATING. 20X0.5ML SINGLE-DOSE VIALS
Restricted access only
Authorized for restricted access only.
Status Restricted Access since May 29, 2023; first marketed June 15, 2015.
- Drug Identification Number (DIN)
- 02416638
- Company (DIN owner)
- Bavarian Nordic AsHellerup, --, Denmark
- Schedule
- Schedule d
- Dosage form
- Suspension
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Smallpox and mpox vaccines J07BX01
- Class
- Human
- Record last updated
- September 28, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| MODIFIED VACCINIA VIRUS (ANKARA-BAVARIAN NORDIC) | 50000000 CCID50 | 0.5 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 21, 2013: NOC 14918New Drug Submission (NDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “imvamune”. A notice may cover another product or only some lots: read it to see what it covers.
- IMVAMUNE Vaccine: Updated Storage Conditions and Shelf LifeJuly 29, 2022 · Biologic or vaccine · New safety information - Product safety